European and French pharmaceutical market assessed by Prescrire in 2005: Mainly bogus innovation

Farmacia Hospitalaria

Volumn 30, Issue 2, 2006, Pages 68-70

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADALIMUMAB; AMPRENAVIR PHOSPHATE; ARIPIPRAZOLE; BORTEZOMIB; CELECOXIB; CETUXIMAB; CHICKENPOX VACCINE; CISPLATIN; CYTARABINE; DACTINOMYCIN; DOCETAXEL; DULOXETINE; EFALIZUMAB; FULVESTRANT; IBRITUMOMAB TIUXETAN; INFLIXIMAB; INSULIN GLARGINE; LAMIVUDINE; MIGLUSTAT; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PEMETREXED; PRAMIPEXOLE; PREGABALIN; STRONTIUM RANELATE; TOLCAPONE; TRASTUZUMAB; UNINDEXED DRUG; WILZIN; ZINC ACETATE;

ACNE; BREAST CANCER; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHICKENPOX; CLINICAL TRIAL; DECISION MAKING; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; DRUG MARKETING; EDITORIAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; HYPERSENSITIVITY REACTION; HYPOMAGNESEMIA; IMMUNE DEFICIENCY; INTERSTITIAL PNEUMONIA; LEUKOPENIA; LIVER DISEASE; MASS IMMUNIZATION; NAUSEA; NEUTROPENIA; PLEURA MESOTHELIOMA; SKIN CANCER; SKIN INFECTION; SKIN MANIFESTATION; SUICIDE ATTEMPT; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; WILSON DISEASE;

EID: 33745801984     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(06)73949-6     Document Type: Editorial

References (10)

1. Prescrire Rédaction. L'année 2005 du médicament: la dérégulation s'accentue. Rev Prescrire 2006; 26 (269): 140-50.
2. Prescrire Editorial Staff. Prescrire's rating system. Prescrire International 2006; 15 (81): 2.
3. Prescrire Rédaction. Le Palmarès 2005 du médicament. Rev Prescrire 2006; 26 (269): 85.
4. Prescrire Rédaction. Amélioration du service médical rendu (ASMR): en France, la Commission de la transparence n'est pas assez exigeante. Rev Prescrire 2004; 24 (256): 859-64.
5. Translated in: Prescrire Editorial Staff. Comparative advantages of new drugs: French authorities are not sufficiently demanding. Prescrire International 2005: 14 (76): 75-9.
6. Prescrire Rédaction. Progrès thérapeutique: les appréciations de l'Agence suédoise du médicament comparées à celles de la revue Prescrire. Rev Prescrire 2005: 25 (264): 622-3.
7. Translated in: Prescrire Editorial Staff. Therapeutic advance: a comparison of assessments made by Prescrire and by the Swedish regulatory agency. Prescrire International 2005; 14 (80): 236.
8. Prescrire Rédaction. Le célécoxib encore sur le marché: au profit de qui? Rev Prescrire 2005; 25 (263): 512-3.
9. Translated in: Prescrire Editorial Staff. Célécoxib still on the market: but for whose benefit? Prescrire International 2005; 14 (79): 177-8.
10. Prescrire Editorial Staff. The drug price explosion. Prescrire International 2005; 14 (75): 34-9.